Abbott (Abbott Park, IL, USA) announced that the FDA would begin implementing Abbott’s STARLIMS software-based LIMS as part of the agency’s initiative to enhance FDA testing laboratories.
As part of a master agreement with Dovèl Technologies (McLean, VA, USA), a company that provides high-end software applications to government organizations, the FDA’s Office of Regulatory Affairs (ORA; Silver Spring, MD, USA) will begin deploying LIMS solutions from STARLIMS, developed to enhance testing of food and drug chemistries, devices, forensics material, and microbiology samples. The ORA operates chiefly five types of laboratories in 14 separate locations. The LIMS solution will provide the needed capability to manage the analytic workflow operations in ORA labs for about 825 users supporting sample accountability, data analysis, document control, report generation, and other lab operation functions.
“We’re looking forward to working on this important initiative,” said Isaac Friedman, head of Abbott’s STARLIMS business. “STARLIMS has a successful track record in implementing web-based LIMS for life sciences organizations, public health laboratories, and a number of federal agencies.”
Based in Hollywood (FL, USA), Abbott’s STARLIMS business is a provider of laboratory information management systems, with more than 20 years of LIMS experience. STARLIMS products help improve the effectiveness of laboratory-sampling processes, support compliance with domestic and international regulations and industry standards, and provide comprehensive reporting, monitoring, and analysis capabilities. STARLIMS software is used for quality assurance and control, testing, and monitoring, and research and development in government, manufacturing, and life sciences organizations.
Abbott is a global healthcare company focused on the discovery, development, manufacture, and marketing of pharmaceuticals and medical products, including nutrition products, devices, and diagnostics.
Related Links:
STARLIMS
Dovèl Technologies
US Food and Drug Administration’s Office of Regulatory Affairs
